E-LIB Suche - Ergebnisse für: Soumerai, J. D.

1

Safety and efficacy of zandelisib plus zanubrutinib in prev..:

Soumerai, Jacob D. ; Diefenbach, Catherine S. ; Jagadeesh, Deepa...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

2

IgG Testing, Immunoglobulin Replacement Therapy, and Infect..:

Soumerai, Jacob D. ; Yousif, Zaid ; Gift, Thais...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

3

Online group-based internal family systems treatment for po..:

Comeau, Alexandra ; Smith, Lia J. ; Smith, Lydia...
Psychological Trauma: Theory, Research, Practice, and Policy. , 2024

Link: https://doi.org/10.1037/..

4

Nivolumab for mismatch-repair-deficient or hypermutated gyn..:

Friedman, Claire F. ; Manning-Geist, Beryl L. ; Zhou, Qin...
Nature Medicine. 30 (2024) 5 - p. 1330-1338 , 2024

Link: https://doi.org/10.1038/..

5

Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) With R..:

Shah, Nirav N. ; Siddiqi, Tanya ; Maloney, David G....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S353-S354 , 2024

Link: https://doi.org/10.1016/..

6

REAL‐WORLD OUTCOMES OF PATIENTS (PT) WITH RELAPSED OR REFRA..:

Soumerai, J. ; Wang, L. ; Gu, F...
Hematological Oncology. 41 (2023) S2 - p. 733-734 , 2023

Link: https://doi.org/10.1002/..

7

Lisocabtagene maraleucel in chronic lymphocytic leukaemia a..:

Siddiqi, Tanya ; Maloney, David G ; Kenderian, Saad S...
The Lancet. 402 (2023) 10402 - p. 641-654 , 2023

Link: https://doi.org/10.1016/..

8

Oral Abstract: CLL-094 Lisocabtagene Maraleucel (liso-cel) ..:

Siddiqi, Tanya ; Maloney, David G. ; Kenderian, Saad S....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S146 , 2023

Link: https://doi.org/10.1016/..

9

CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECOND..:

Karschnia, Philipp ; Arrillaga-Romany, Isabel ; Eichler, April...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v71-v71 , 2023

Link: https://doi.org/10.1093/..

10

Metabolic parameters predict survival and toxicity in chime..:

Ababneh, Hazim S. ; Ng, Andrea K. ; Abramson, Jeremy S....
Hematological Oncology. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

11

Ayres Sensory Integration Therapy for a Child With Rett Syn..:

Rocco, Karen ; Drobnyk, Wendy` ; Bruce, Susan.
Clinical Medicine Insights: Pediatrics. 17 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

12

LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBR..:

Soumerai, J. D. ; Dogan, A. ; Seshan, V....
Hematological Oncology. 41 (2023) S2 - p. 233-235 , 2023

Link: https://doi.org/10.1002/..

13

LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R CHRONIC LYMPHOCY..:

Siddiqi, T. ; Maloney, D. G. ; Kenderian, S. S....
Hematological Oncology. 41 (2023) S2 - p. 60-62 , 2023

Link: https://doi.org/10.1002/..

14

Neurotoxicity and management of primary and secondary centr..:

Karschnia, Philipp ; Arrillaga-Romany, Isabel C ; Eichler, April...
Neuro-Oncology. 25 (2023) 12 - p. 2239-2249 , 2023

Link: https://doi.org/10.1093/..

15

PATTERNS OF IMMUNOGLOBULIN G TESTING AND INFECTION OUTCOMES..:

Soumerai, J. D. ; Yousif, Z. ; Gift, T....
Hematological Oncology. 41 (2023) S2 - p. 744-745 , 2023

Link: https://doi.org/10.1002/..